Buy or sell Adagio Medical stock pre IPO via an EquityZen fund
Adagio Medical Stock
Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.
About Adagio Medical Stock
Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases. Adagio Medical is committed to providing electrophysiologists innovative cryoablation catheters that create safe, continuous, transmural lesions to treat cardiac arrhythmias anywhere in the heart, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded in 2011 and is based in Laguna Hills, California.
Founder, Chief Executive Officer and President
Vice President, Research & Development
Chief Operating Officer
Vice President & General Counsel
Jacqueline Arnold Collins